Evaluation of the In-Vitro Dissolution Permeation Systems 1 (IDAS1) as a potential tool to monitor for unexpected changes in generic medicaments in poorly regulated markets

Authors: Rodriguez, N; Grosso, M; Galvez, B; Calderon, G; Lau, L; Turner, V.A.; Hidalgo, I.J.

Eur J Pharm Sci. 2021 Jun 1:161:105791

DOI: 10.1016/j.ejps.2021.105791

Access the publication at: https://pubmed.ncbi.nlm.nih.gov/33691154/